+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Montelukast"

Global Montelukast Sodium Market - Product Thumbnail Image

Global Montelukast Sodium Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
Investigation Report on China's Montelukast Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Montelukast Market, 2018-2022

  • Report
  • November 2018
  • 30 Pages
  • China
From
Drug Overview: Singulair - Product Thumbnail Image

Drug Overview: Singulair

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
Global Montelukast Sodium Market 2022-2026 - Product Thumbnail Image

Global Montelukast Sodium Market 2022-2026

  • Report
  • May 2022
  • 120 Pages
  • Global
From
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Montelukast is a leukotriene receptor antagonist used to treat asthma and allergic rhinitis. It is a prescription drug that is taken orally, usually once a day. Montelukast works by blocking the action of leukotrienes, which are chemicals that cause inflammation in the airways. This helps to reduce the symptoms of asthma and allergic rhinitis, such as wheezing, coughing, and difficulty breathing. Montelukast is generally well tolerated and has few side effects. Montelukast is one of several drugs used to treat asthma and allergic rhinitis. Other drugs used to treat these conditions include inhaled corticosteroids, long-acting beta agonists, and anti-IgE therapy. Montelukast is often used in combination with other drugs to provide the best possible treatment. Several companies produce and market Montelukast, including Merck & Co., Inc., Teva Pharmaceuticals, and Mylan Pharmaceuticals. These companies produce generic versions of the drug, as well as branded versions. Montelukast is also available in combination with other drugs, such as fluticasone and salmeterol. Show Less Read more